Acelarin
Cat. No.:YN290020
CAS No. :840506-29-8
产品名称: | Acelarin |
CAS No.: | 840506-29-8 |
Chemical Name: | N-(2'-deoxy-2',2'-difluoro-P-phenyl-5'-cytidylyl)-L-alanine, phenylmethyl ester |
Synonyms: | NUC-1031 |
分子量: | 580.47 |
分子式: | C₂₅H₂₇F₂N₄O₈P |
SMILES: | O=C1N=C(N)C=CN1[C@@H]2O[C@H](COP(OC3=CC=CC=C3)(N[C@H](C(OCC4=CC=CC=C4)=O)C)=O)[C@@H](O)C2(F)F |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | Acelarin(NUC-1031)是广泛使用的核苷类似物吉西他滨的蛋白转化和增强。 |
IC50和靶点: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Thornton, P.J., Kadri, H., Miccoli, A., et al.Nucleoside phosphate and phosphonate prodrug clinical candidatesJ. Med. Chem.59(23),10400-10410(2016)
Slusarczyk, M., Lopez, M.H., Balzarini, J., et al.Application of ProTide technology to gemcitabine: A successful approach to overcome the key cancer resistance mechanisms leads to a new agent (NUC-1031) in clinical developmentJ. Med. Chem.57(4),1531-1542(2014)
McGuigan, C., Habib, N.A., Wasan, H.S., et al.A phosphoramidate ProTide (NUC-1031) and acquired and intrinsic resistance to gemcitabineJ. Clin. Oncol.29(15_suppl),e13540(2016)